ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för salsalate. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

24 träffar

Bibliografisk träff 2017-02-06

Drugs and drug-like molecules can modulate the function of mucosal-associated invariant T cells.

Keller AN, Eckle SB, Xu W, Liu L, Hughes VA, Mak JY, Meehan BS, Pediongco T, Birkinshaw RW, Chen Z, Wang H, D'Souza C, Kjer-Nielsen L, Gherardin NA, Godfrey DI, Kostenko L, Corbett AJ, Purcell AW, Fairlie DP, McCluskey J, Rossjohn J.

Nat Immunol · research support, non-u.s. gov't; journal article · DOI 10.1038/ni.3679

Bibliografisk träff 2013-10-15

Targeting inflammation using salsalate in patients with type 2 diabetes: effects on flow-mediated dilation (TINSAL-FMD).

Goldfine AB, Buck JS, Desouza C, Fonseca V, Chen YD, Shoelson SE, Jablonski KA, Creager MA, TINSAL-FMD (Targeting Inflammation Using Salsalate in Type 2 Diabetes–Flow-Mediated Dilation) Ancillary Study Team.

Diabetes Care · research support, non-u.s. gov't; research-article; multicenter study; randomized controlled trial; journal article; research support, n.i.h., extramural · DOI 10.2337/dc13-0859

Bibliografisk träff 2013-08-13

Salsalate and adiponectin ameliorate hepatic steatosis by inhibition of the hepatokine fetuin-A.

Jung TW, Youn BS, Choi HY, Lee SY, Hong HC, Yang SJ, Yoo HJ, Kim BH, Baik SH, Choi KM.

Biochem Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bcp.2013.07.034

Bibliografisk träff 2013-07-19

AMPK: mediating the metabolic effects of salicylate-based drugs?

Steinberg GR, Dandapani M, Hardie DG.

Trends Endocrinol Metab · research support, non-u.s. gov't; research-article; journal article · DOI 10.1016/j.tem.2013.06.002

Bibliografisk träff 2013-07-01

AMPK: a target for drugs and natural products with effects on both diabetes and cancer.

Hardie DG.

Diabetes · research support, non-u.s. gov't; review; discussion; journal article · DOI 10.2337/db13-0368

Bibliografisk träff 2013-07-01

Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial.

Goldfine AB, Fonseca V, Jablonski KA, Chen YD, Tipton L, Staten MA, Shoelson SE, Targeting Inflammation Using Salsalate in Type 2 Diabetes Study Team.

Ann Intern Med · clinical trial, phase ii; research-article; multicenter study; randomized controlled trial; journal article; research support, n.i.h., extramural · DOI 10.7326/0003-4819-159-1-201307020-00003

Bibliografisk träff 2013-07-01

Summaries for patients. Salsalate for type 2 diabetes mellitus.

Författaruppgift saknas

Ann Intern Med · patient education handout; journal article · DOI 10.7326/0003-4819-159-1-201307020-00001

Bibliografisk träff 2013-06-18

Salsalate and Adiponectin Improve Palmitate-Induced Insulin Resistance via Inhibition of Selenoprotein P through the AMPK-FOXO1α Pathway.

Jung TW, Choi HY, Lee SY, Hong HC, Yang SJ, Yoo HJ, Youn BS, Baik SH, Choi KM.

PLoS One · research-article; journal article · DOI 10.1371/journal.pone.0066529

Bibliografisk träff 2013-05-13

Open-label salsalate for the treatment of pre-diabetes in people with schizophrenia.

Keller WR, Fischer BA, McMahon RP, Meyer W, Buchanan RW.

Schizophr Res · letter · DOI 10.1016/j.schres.2013.04.028

Bibliografisk träff 2013-01-31

A randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons with abnormal glucose tolerance.

Goldfine AB, Conlin PR, Halperin F, Koska J, Permana P, Schwenke D, Shoelson SE, Reaven PD.

Diabetologia · research support, non-u.s. gov't; research-article; multicenter study; randomized controlled trial; journal article; research support, n.i.h., extramural · DOI 10.1007/s00125-012-2819-3

Bibliografisk träff 2012-11-01

Reduction of insulin resistance and plasma glucose level by salsalate treatment in persons with prediabetes.

Faghihimani E, Aminorroaya A, Rezvanian H, Adibi P, Ismail-Beigi F, Amini M.

Endocr Pract · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.4158/ep12064.or

Bibliografisk träff 2012-07-26

Pharmacokinetics of salsalate and salicylic acid in normal and diabetic rats.

Cao Y, DuBois DC, Almon RR, Jusko WJ.

Biopharm Drug Dispos · comparative study; research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1002/bdd.1797

Bibliografisk träff 2012-04-19

The ancient drug salicylate directly activates AMP-activated protein kinase.

Hawley SA, Fullerton MD, Ross FA, Schertzer JD, Chevtzoff C, Walker KJ, Peggie MW, Zibrova D, Green KA, Mustard KJ, Kemp BE, Sakamoto K, Steinberg GR, Hardie DG.

Science · research support, non-u.s. gov't; research-article; journal article · DOI 10.1126/science.1215327

Bibliografisk träff 2012-04-01

[Benefits and risks of current pharmacotherapy in the treatment of type 2 diabetes].

Schindler C, Barthel A, Fischer S, Bornstein SR, Kirch W.

Internist (Berl) · journal article; english abstract · DOI 10.1007/s00108-012-3014-9

Bibliografisk träff 2012-02-22

Salicylate downregulates 11β-HSD1 expression in adipose tissue in obese mice and in humans, mediating insulin sensitization.

Nixon M, Wake DJ, Livingstone DE, Stimson RH, Esteves CL, Seckl JR, Chapman KE, Andrew R, Walker BR.

Diabetes · research support, non-u.s. gov't; research-article; randomized controlled trial; journal article · DOI 10.2337/db11-0931

Bibliografisk träff 2011-09-22

Salsalate improves glycemic control in patients with newly diagnosed type 2 diabetes.

Faghihimani E, Aminorroaya A, Rezvanian H, Adibi P, Ismail-Beigi F, Amini M.

Acta Diabetol · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1007/s00592-011-0329-2

Bibliografisk träff 2011-09-08

Modeling diabetes disease progression and salsalate intervention in Goto-Kakizaki rats.

Cao Y, Dubois DC, Sun H, Almon RR, Jusko WJ.

J Pharmacol Exp Ther · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1124/jpet.111.185686

Bibliografisk träff 2011-07-20

Full-spectrum antioxidant therapy featuring astaxanthin coupled with lipoprivic strategies and salsalate for management of non-alcoholic fatty liver disease.

McCarty MF.

Med Hypotheses · journal article · DOI 10.1016/j.mehy.2011.06.029

Bibliografisk träff 2011-06-01

Is there a role for immune and anti-in-flammatory therapy in type 2 diabetes?

Sathyapalan T, Atkin SL.

Minerva Endocrinol · review; journal article

Bibliografisk träff 2011-05-26

Salsalate attenuates free fatty acid-induced microvascular and metabolic insulin resistance in humans.

Chai W, Liu J, Jahn LA, Fowler DE, Barrett EJ, Liu Z.

Diabetes Care · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.2337/dc10-2345

Bibliografisk träff 2011-02-02

Stimulation of human whole-body energy expenditure by salsalate is fueled by higher lipid oxidation under fasting conditions and by higher oxidative glucose disposal under insulin-stimulated conditions.

Meex RC, Phielix E, Moonen-Kornips E, Schrauwen P, Hesselink MK.

J Clin Endocrinol Metab · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1210/jc.2010-1816

Bibliografisk träff 2010-09-28

Effects of salsalate therapy on recovery from vascular injury in female Zucker fatty rats.

Murthy SN, Desouza CV, Bost NW, Hilaire RC, Casey DB, Badejo AM, Dhaliwal JS, McGee J, McNamara DB, Kadowitz PJ, Fonseca VA.

Diabetes · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.2337/db09-1761

Bibliografisk träff 2010-07-01

Salsalate is poorly tolerated and fails to improve endothelial function in virologically suppressed HIV-infected adults.

Hileman CO, Carman TL, Gripshover BM, O'Riordan M, Storer NJ, Harrill DE, White CA, McComsey GA.

AIDS · research support, non-u.s. gov't; randomized controlled trial; journal article; research support, n.i.h., extramural · DOI 10.1097/qad.0b013e32833c3251

Bibliografisk träff 2009-09-10

Beta-lactamase inhibitory component from the roots of Fissistigma cavaleriei.

Yang Z, Niu Y, Le Y, Ma X, Qiao C.

Phytomedicine · research support, non-u.s. gov't; journal article · DOI 10.1016/j.phymed.2009.08.003